PD-L1 expression is found in 26-75% (26) of patients with higher expression in Activated B-Cell (ABC) DLBCL, presumably due to the constitutively activated NF-κB as it is in Epstein Barr Virus (EBV)-positive DLBCL (27). This evidence concerns the gene CD274 and diffuse large B-cell lymphoma.